| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 01/04/2007 | WO2006044595A3 Effervescent pressed gum tablet compositions |
| 01/04/2007 | WO2006043083A3 Liposomes enclosing a radionuclide and a cytotoxic agent for combination therapy |
| 01/04/2007 | WO2005112888A8 Methods for making injectable polymer hydrogels |
| 01/04/2007 | WO2005015158A3 T1r hetero-oligomeric taste receptors, cell lines that express said receptors, and taste compounds |
| 01/04/2007 | US20070005044 Implantable pump with infinitely variable resistor |
| 01/04/2007 | US20070005043 Osmotic Intraosseous Drug Delivery System |
| 01/04/2007 | US20070005042 Programmable Intraosseous Drug Delivery System |
| 01/04/2007 | US20070004914 enhance humoral and cell-mediated immune responses to vaccine antigens; 2-deoxy-2-amino- beta -D-glucopyranose (glucosamine) glycosidically linked to an cyclic aminoalkyl (aglycon) group; viricide; immunostimulant; antiischemic agent |
| 01/04/2007 | US20070004896 Active energy radiation hardenable skin plaster composition and skin plaster |
| 01/04/2007 | US20070004847 Emulsion composition of modified polypropylene |
| 01/04/2007 | US20070004784 Oxazole-, oxadiazole- or oxatriazole- functionalized bisarylsulfonamides inhibit the intermediate conductance, calcium activated potassium channel; sickle cell anemia and glaucoma; antiinflammatory, antiproliferative, bronchodilator agents |
| 01/04/2007 | US20070004756 Pharmaceutical compositions |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004688 Mixture with surfactant; bone disorders; controlling immunology response; cancer therapy |
| 01/04/2007 | US20070004668 Antisense permeation enhancers |
| 01/04/2007 | US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus |
| 01/04/2007 | US20070003637 Bicarbonate-based solutions for dialysis therapies |
| 01/04/2007 | US20070003631 Micronetworks, microchannels/cylinders and the process for making the same |
| 01/04/2007 | US20070003630 Anti-angiogenic compositions and methods of use |
| 01/04/2007 | US20070003629 Anticancer agents; prevent forming blood vessels; removal blockage |
| 01/04/2007 | US20070003628 Nanoparticulate clopidogrel formulations |
| 01/04/2007 | US20070003627 Hemorrhoidal compositions and method of use |
| 01/04/2007 | US20070003626 Sterile in-situ microcarrier forming gelled polymeric dispersions and processes to manufacture the same |
| 01/04/2007 | US20070003625 Biodegradable branched polylactide derivatives capable of forming polymeric micelles, and their preparation method and use |
| 01/04/2007 | US20070003624 Semi-permeable compositions providing reduced drying time for osmotic dosage forms |
| 01/04/2007 | US20070003623 Formulations of conjugated estrogens and bazedoxifene |
| 01/04/2007 | US20070003622 Diphenhydramine containing dosage form |
| 01/04/2007 | US20070003621 Dosage forms for movement disorder treatment |
| 01/04/2007 | US20070003620 Morphine sulfate microgranules, method for preparing same and compositions containing same |
| 01/04/2007 | US20070003619 Coated particles for sustained-release pharmaceutical administration |
| 01/04/2007 | US20070003618 Sustained-release tramadol formulations with 24-hour efficacy |
| 01/04/2007 | US20070003617 Morphine controlled release system |
| 01/04/2007 | US20070003616 Process for the production of an abuse-proofed dosage form |
| 01/04/2007 | US20070003615 Nanoparticulate clopidogrel and aspirin combination formulations |
| 01/04/2007 | US20070003614 Pharmaceutical compositions comprising active vitamin D compounds |
| 01/04/2007 | US20070003613 Preparations to support maintenance of acid-alkaline balance in the human body and methods directed to using same |
| 01/04/2007 | US20070003612 Capsule |
| 01/04/2007 | US20070003611 Novel method of granulating calcium carbonate and products provided therefrom |
| 01/04/2007 | US20070003610 Application of lipid vehicles and use for drug delivery |
| 01/04/2007 | US20070003609 Vectorization of dsRNA by cationic particles and topical use |
| 01/04/2007 | US20070003608 Compounds, compositions and methods for the treatment of viral infections and other medical disorders |
| 01/04/2007 | US20070003607 Neutral liposome-encapsulated compounds and methods of making and using thereof |
| 01/04/2007 | US20070003605 Non-discoloring sterilized wipe |
| 01/04/2007 | US20070003604 Tissue coverings bearing customized tissue images |
| 01/04/2007 | US20070003603 Antimicrobial silver compositions |
| 01/04/2007 | US20070003598 Osteogenic implants for soft tissue |
| 01/04/2007 | US20070003592 Biodegradable phase separated segmented multi block co-polymers |
| 01/04/2007 | US20070003590 Methods of Treating Microbial Infections |
| 01/04/2007 | US20070003582 Medicine for the treatment of acne and for reversing the signs of age and sun damage and method for using same |
| 01/04/2007 | US20070003581 Microemulsion for cosmetic or pharmaceutical use containing an active ingredient |
| 01/04/2007 | US20070003562 Chimera molecule containing protein and merozoites surface protein; induce immunology response against antigen |
| 01/04/2007 | US20070003510 Preparations containing an extract of eperua falcata and/or constituents of the latter |
| 01/04/2007 | US20070003503 Tissue enhancement implant and method |
| 01/04/2007 | US20070003502 Skin preparation for external use characterized by containing sugar derivative of alpha, alpha-trehalose |
| 01/04/2007 | US20070003492 Porous silica having substance carried thereon |
| 01/04/2007 | US20070003491 administering polylysine to mammals as dietetics, for prevention and/or treatment of obesity |
| 01/04/2007 | US20070003490 Medicated gumstick for treatment in anti-inflammatory conditions and prophylaxis against NSAID gastropathy |
| 01/04/2007 | US20070003489 is generated and delivered simultaneously using a syringe based device; comprises a sclerosant liquid, polidocanol solution, and gas N2, xenon; by inter alia causing a localised inflammatory reaction, favor the elimination of varicose veins and other disorders involving venous malformation |
| 01/04/2007 | US20070003488 Methods of preparing a foam comprising a sclerosing agent |
| 01/04/2007 | US20070003487 Composition, method and pharmaceutical preparation for pharmaceutical spray suspensions |
| 01/04/2007 | US20070003480 Liposomal composition comprising haptotactic peptides |
| 01/04/2007 | DE202006014131U1 Opioid-orale Dosisformen mit verlängerter Freisetzung mit reduziertem alkohol-induziertem "Dosis Dumping" Opioid oral dosage forms with prolonged release of reduced alcohol-induced "dose dumping" |
| 01/04/2007 | DE112004002099T5 Anionen bindende Polymere und Verwendungen davon Anion-binding polymers and uses thereof |
| 01/04/2007 | CA2617319A1 Radiolabeled-pegylation of ligands for use as imaging agents |
| 01/04/2007 | CA2613933A1 Methods and dosage forms for reducing side effects of carbamate compounds |
| 01/04/2007 | CA2613705A1 Compositions and methods for less immunogenic pr0tein-lip1d complexes |
| 01/04/2007 | CA2613662A1 Antimicrobial materials |
| 01/04/2007 | CA2613631A1 Improved dosage forms for movement disorder treatment |
| 01/04/2007 | CA2613617A1 Compositions and methods for enhancement of sexual function |
| 01/04/2007 | CA2613466A1 Nanoparticulate megestrol formulations |
| 01/04/2007 | CA2613407A1 Pharmaceutical sustained release compositions and processes thereof |
| 01/04/2007 | CA2613403A1 Modified release pharmaceutical compositions on the basis of two polymers and processes thereof |
| 01/04/2007 | CA2613357A1 Semi-permeable compositions providing reduced drying time for osmotic dosage forms |
| 01/04/2007 | CA2613355A1 A direct drug delivery system based on thermally responsive biopolymers |
| 01/04/2007 | CA2613281A1 Water soluble analgesic formulations and methods for production |
| 01/04/2007 | CA2613280A1 Drug/polymer composite materials and methods of making the same |
| 01/04/2007 | CA2613263A1 Drink comprising a combination of fish oil and probiotics |
| 01/04/2007 | CA2613107A1 Delayed release or extended-delayed release dosage forms of pramipexole |
| 01/04/2007 | CA2613102A1 Formulations of conjugated estrogens and bazedoxifene |
| 01/04/2007 | CA2613044A1 Medicament delivery article, accessory & system |
| 01/04/2007 | CA2612917A1 Rapidly absorbing oral formulations of pde5 inhibitors |
| 01/04/2007 | CA2612688A1 Osteograft treatment to promote osteoinduction and osteograft incorporation |
| 01/04/2007 | CA2612019A1 Dronabinol treatment for migraines |
| 01/04/2007 | CA2608629A1 Orally disintegrating powder comprising cilostazol and mannitol |
| 01/04/2007 | CA2598204A1 Stabilized hme composition with small drug particles |
| 01/03/2007 | EP1739171A1 Novel gene participating in epidermal differentiation and use thereof |
| 01/03/2007 | EP1739086A2 Pharmaceutical compositions of risperidone in aqueous solution |
| 01/03/2007 | EP1738768A1 Aqueous formulation for vecuronium bromide |
| 01/03/2007 | EP1738756A2 Esmolol formulation |
| 01/03/2007 | EP1738755A1 Tablet containing branched chain amino acid and process for producing the same |
| 01/03/2007 | EP1738754A1 Solid pharmaceutical preparation |
| 01/03/2007 | EP1738751A2 Spaced drug delivery system |
| 01/03/2007 | EP1738750A1 Method of granulating calcium carbonate and products provided therefrom |
| 01/03/2007 | EP1738749A1 Pharmaceutical compositions providing enhanced drug concentrations |
| 01/03/2007 | EP1738657A2 Sugar alcohol composition for tableting |
| 01/03/2007 | EP1738026A1 Paper tissue with high lotion transferability |
| 01/03/2007 | EP1737499A2 Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor |
| 01/03/2007 | EP1737494A2 Freeze-dried, free-flowing, particulate composition having improved palatability |
| 01/03/2007 | EP1737485A2 Mucinous glycoprotein (muc-1) vaccine |
| 01/03/2007 | EP1737455A1 Controlled release pharmaceutical composition of tolperisone for oral administration |